Distinct Regulation of Autophagic Activity by Atg14L and Rubicon Associated with Beclin 1-phosphatidylinositol-3-kinase Complex
Overview
Authors
Affiliations
Beclin 1, a mammalian autophagy protein that has been implicated in development, tumour suppression, neurodegeneration and cell death, exists in a complex with Vps34, the class III phosphatidylinositol-3-kinase (PI(3)K) that mediates multiple vesicle-trafficking processes including endocytosis and autophagy. However, the precise role of the Beclin 1-Vps34 complex in autophagy regulation remains to be elucidated. Combining mouse genetics and biochemistry, we have identified a large in vivo Beclin 1 complex containing the known proteins Vps34, p150/Vps15 and UVRAG, as well as two newly identified proteins, Atg14L (yeast Atg14-like) and Rubicon (RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein). Characterization of the new proteins revealed that Atg14L enhances Vps34 lipid kinase activity and upregulates autophagy, whereas Rubicon reduces Vps34 activity and downregulates autophagy. We show that Beclin 1 and Atg14L synergistically promote the formation of double-membraned organelles that are associated with Atg5 and Atg12, whereas forced expression of Rubicon results in aberrant late endosomal/lysosomal structures and impaired autophagosome maturation. We hypothesize that by forming distinct protein complexes, Beclin 1 and its binding proteins orchestrate the precise function of the class III PI(3)K in regulating autophagy at multiple steps.
Wang X, Li S, Lin S, Han Y, Zhan T, Huang Z Cell Res. 2025; .
PMID: 40055523 DOI: 10.1038/s41422-025-01085-9.
Sex Disparity in Cancer: Role of Autophagy and Estrogen Receptors.
Vona R, Cittadini C, Ortona E, Matarrese P Cells. 2025; 14(4).
PMID: 39996745 PMC: 11854201. DOI: 10.3390/cells14040273.
Acetylation modification in the regulation of macroautophagy.
Huang L, Guo H Adv Biotechnol (Singap). 2025; 2(2):19.
PMID: 39883319 PMC: 11740868. DOI: 10.1007/s44307-024-00027-7.
Autophagy in brain tumors: molecular mechanisms, challenges, and therapeutic opportunities.
Zhang J, Zhang J, Yang C J Transl Med. 2025; 23(1):52.
PMID: 39806481 PMC: 11727735. DOI: 10.1186/s12967-024-06063-0.
Zhang H, Xie S, Deng W Biomolecules. 2025; 14(12.
PMID: 39766321 PMC: 11674137. DOI: 10.3390/biom14121614.